mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.0099 |
0.8 |
mRNA |
Irinotecan |
FIMM |
pan-cancer |
AAC |
-0.037 |
0.8 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
Nilotinib |
FIMM |
pan-cancer |
AAC |
0.053 |
0.8 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
-0.009 |
0.8 |